Aarti Pharmalabs Ltd Q2FY26 consolidated net profit slides to Rs. 27.92 crores

Aarti Pharmalabs Limited has reported Consolidated financial results for the period ended September 30, 2025.

Financial Results (Q2 FY2026) - QoQ Comparison

The company has reported total income of Rs. 418.3851 crores during the period ended September 30, 2025 as compared to Rs. 387.7865 crores during the period ended June 30, 2025.

The company has posted net profit / (loss) of Rs. 27.9231 crores for the period ended September 30, 2025 as against net profit / (loss) of Rs. 49.5013 crores for the period ended June 30, 2025.

The company has reported EPS of Rs. 3.08 for the period ended September 30, 2025 as compared to Rs. 5.46 for the period ended June 30, 2025.

Financials	Q2 FY2026	Q1 FY2026	% Change
Total Income	₹ 418.3851 crs	₹387.7865 crs	7.89%
Net Profit	₹27.9231 crs	₹49.5013 crs	-43.59%
EPS	₹3.08	₹5.46	-43.59%

Financial Results (Q2 FY2026) - YoY Comparison

The company has reported total income of Rs. 418.3851 crores during the period ended September 30, 2025 as compared to Rs.462.5087 crores during the period ended September 30, 2024.

The company has posted net profit / (loss) of Rs.27.9231 crores for the period ended September 30, 2025 as against net profit / (loss) of Rs.54.6225 crores for the period ended September 30, 2024.

The company has reported EPS of Rs.3.08 for the period ended September 30, 2025 as compared to Rs.6.02 for the period ended September 30, 2024.

Financials	Q2 FY2026	Q2 FY2025	% Change
Total Income	₹ 418.3851 crs	₹462.5087 crs	-9.54%
Net Profit	₹27.9231 crs	₹54.6225 crs	-48.88%
EPS	₹3.08	₹6.02	-48.84%

Financial Results (Half Year Ended FY2026) - YoY Comparison

The company has reported total income of Rs.806.1715 crores during the 6 Months period ended September 30, 2025 as compared to Rs.1020.2183 crores during the 6 Months period ended September 30, 2024.

The company has posted net profit / (loss) of Rs.77.4509 crores for the 6 Months period ended September 30, 2025 as against net profit / (loss) of Rs.110.0761 crores for the 6 Months period ended September 30, 2024.

The company has reported EPS of Rs.8.54 for the 6 Months period ended September 30, 2025 as compared to Rs.12.14 for the 6 Months period ended September 30, 2024.

Financials	Half Year Ended FY2026	Half Year Ended FY2025	% Change
Total Income	₹806.1715 crs	₹1020.2183 crs	-20.98%
Net Profit	₹77.4509 crs	₹110.0761 crs	-29.64%
EPS	₹8.54	₹12.14	-29.65%

Shares of Aarti Pharmalabs Limited was last trading in BSE at Rs. 864.05 as compared to the previous close of Rs. 843.00. The total number of shares traded during the day was 3200 in over 353 trades.

The stock hit an intraday high of Rs. 869.55 and intraday low of 836.75. The net turnover during the day was Rs. 2726186.00.

Source : Equity Bulls

Keywords

AartiPharmalabs Q2FY26 Q2FY2026 H1FY26 H1FY2026 ResultUpdate